Federal contract award
75FCMC21F0003
MEDICAID FINANCIAL OVERSIGHT ANALYSIS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | OFC OF ACQUISITION AND GRANTS MGMT |
| NAICS | 541720 — Research and Development in the Social Sciences and Humanities |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75FCMC19D0092 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $10.3M |
| Current contract value | $10.3M |
| Potential contract value / ceiling | $10.8M |
| Start date | Sep 13, 2021 |
| Current end date | Sep 12, 2026 |
| Potential end date | Sep 12, 2026 |
| Latest award activity | Sep 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2026 | P00012 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Mar 12, 2026 | P00011 | $300.0K | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Apr 24, 2025 | P00010 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Mar 7, 2025 | P00009 | $1.6M | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Nov 13, 2024 | P00008 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Mar 11, 2024 | P00007 | $2.4M | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Dec 19, 2023 | P00006 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Feb 10, 2023 | P00005 | $2.5M | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Oct 18, 2022 | P00004 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Jul 19, 2022 | P00002 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Jul 18, 2022 | P00003 | $2.2M | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Mar 8, 2022 | P00001 | $0 | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
| Sep 10, 2021 | 0 | $1.2M | MEDICAID FINANCIAL OVERSIGHT ANALYSIS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.